Apixaban is an anticoagulant for the treatment of venous thromboembolic events. It is a direct factor Xa inhibitor. Apixaban is FDA approved for treatment and secondary prophylaxis of DVT and PE.
Apixaban is an anticoagulant for the treatment of venous thromboembolic events. It is a direct factor Xa inhibitor. Apixaban is FDA approved for treatment and secondary prophylaxis of DVT and PE.